Determination of the Glycemic Index of Breads made from a Novel Wheat

Phase 4

Completed

• Conditions: Healthy volunteers with fasting glucose 3.5-5.5 mmol/L; Metabolic and Endocrine - Normal metabolism and endocrine development and function

• Registration Number: ACTRN12606000366550
• Lead Sponsor: Commonwealth Scientific Industrial Research Organisation, Human Nutrition

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2006-08-22
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 14

Inclusion Criteria

Normal fasting blood glucose concentration (3.5-5.5 mmol/L).

Exclusion Criteria

Presence of diabetes (self-reported)Sufferers of bleeding disordersKnown food allergy, hypersensitivity or intolerance to cereal foods (eg celiac sprue) Taking medications known to influence glucose tolerance (oral contraceptives are excepted) such as sulphonylureas, metformin and thiazolidinediones.Persons considered by the investigator to be unwilling, unlikely or unable to comprehend or comply with the study protocol Participation in another research study within 30 days preceding the start of this studyHistory or presence of GI, renal or hepatic disease of any cause.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Glucose blood samples[At each visit at times 0, 15, 30, 45, 60, 90 & 120 mins.]

Secondary Outcome Measures

Name	Time	Method
Insulin blood samples[At each visit at times 0, 15, 30, 45, 60, 90 & 120 mins.]